Evaxion Biotech A/S ADR EVAX 深 滬
等待開盤 08-13 09:30:00 美东时间
2.85
+0.080
+2.89%
華盛通- 最 高2.885
- 今 開2.80
- 成交量 2.45万股
- 最 低 2.7235
- 昨 收 2.77
- 總市值 1800.23万
- 52周最高 17.75
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 1.20
- 委 比 95.12%
- 總股本 631.66万
- 歷史最高 1252.00
- 量 比 0.41
- 振 幅 5.83%
- 歷史最低 2.7235
- 每 手 1
- 風險率 5.32%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Evaxion to present two-year clinical efficacy data from phase 2 trial with AI-designed personalized cancer vaccine EVX-01 at the ESMO Congress 2025
Evaxion A/S will present two-year clinical data from its phase 2 trial for EVX-01, a personalized cancer vaccine for advanced melanoma, at the 2025 ESMO Congress in Berlin. EVX-01, developed using Evaxion's AI-Immunology™ platform, has shown promising results in early trials, including a 69% Overall Response Rate and tumor reduction in 15 out of 16 patients. The presentation will highlight long-term efficacy and immune response data. The phase 2 ...
07-25 13:00
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Sonnet BioTherapeutics (NASDAQ:SONN) shares rose 239.4% to $17.55 dur...
07-14 20:08
Evaxion Finalizes Agreement With EIB To Convert Debt Into Equity; EIB To Convert €3.5M Of €7M Loan To Evaxion Into Equity Via Purchase Of Ordinary Evaxion Warrants At $4.87
Evaxion and the European Investment Bank (EIB) have finalized a debt settlement agreement of €3.5 million out of Evaxion's €7 million loan with EIB, to be used for EIB to purchase €3.5 million worth of ordinary Evaxion
07-11 20:07
Evaxion announces changes to Executive Management to optimize the value of proprietary AI-Immunology™ platform and portfolio
Christian Kanstrup has stepped down as CEO of Evaxion A/S. Dr. Birgitte Rønø, the Chief Scientific Officer, has been appointed interim CEO, and the search for a new permanent CEO has begun. Additionally, Thomas Schmidt has been named permanent Chief Financial Officer. The company aims to optimize the value of its AI-Immunology™ platform under these leadership changes.
07-01 12:30
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Adial Pharmaceuticals (NASDAQ:ADIL) stock moved upwards by 19.6% to $0...
06-26 05:06
Evaxion Initiates Work To Develop New Preventive Vaccine Against Group A Streptococcus; New Vaccine Program Added To Evaxion's Pipeline Under Name EVX-B4
Initial computational analysis demonstrated that Evaxion's AI-Immunology™ platform can identify novel vaccine targets to combat Group A Streptococcus (GAS)New vaccine program is added to Evaxion's pipeline under
06-25 20:15
Evaxion expands R&D pipeline with new vaccine program targeting Group A Streptococcus
Evaxion A/S has initiated a new vaccine program, EVX-B4, to combat Group A Streptococcus (GAS), a bacteria causing millions of infections globally. Using its AI-Immunology™ platform, the company aims to identify novel vaccine targets, addressing the urgent need for preventive measures against GAS infections, which can lead to severe complications like rheumatic heart disease and necrotizing fasciitis. EVX-B4 aligns with Evaxion’s strategy to part...
06-25 12:00
2025新财富创富榜出炉：张一鸣问鼎首富，钟睒睒跌至第二
整体来看，今年上榜的500位企业家（或家族）总持股市值为13.7万亿元，同比上涨11%，平均持股市值为273.8亿元，上榜门槛为66.2亿元，持股市值百亿以上的企业家达341位。
06-24 15:51
Evaxion Awarded Gates Foundation Grant To Advance AI-Powered Vaccine Design Targeting Global Polio Eradication, Using Its AI-Immunology Platform To Develop Novel Antigen Constructs Amid Ongoing Risk Of Global Resurgence; No Financial Terms Disclosed
Evaxion awarded a grant from the Gates FoundationGrant funds research aimed at ultimately eradicating polio, a highly infectious viral diseaseEvaxion will apply its leading AI-Immunology™ platform to identify and
06-03 21:19
Evaxion receives grant funding to design new polio vaccine
Evaxion awarded a Gates Foundation grant to develop a new polio vaccine using its AI-Immunology™ platform. The project aims to identify and combine antigens to design novel vaccine constructs, eliminating the need for live viruses. With polio risks persisting, this breakthrough approach could help achieve global eradication.
06-03 13:15
